MIRA INFORM REPORT

 

 

Report Date :

18.10.2013

 

IDENTIFICATION DETAILS

 

Name :

GOLDENCROSS PHARMA PRIVATE LIMITED

 

 

Registered Office :

12, Gunbow Street, Fort, Mumbai - 400001, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

21.01.2000

 

 

Com. Reg. No.:

11-123766

 

 

Capital Investment / Paid-up Capital :

Rs.0.460 Million

 

 

CIN No.:

[Company Identification No.]

U24239MH2000PTC123766

 

 

PAN No.:

[Permanent Account No.]

AABCG0541J

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

 

No. of Employees :

Information declined by the management.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (42)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 7300000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

Latest financial of 2012 are not available with us. As per previous, overall financial performance of the company strong and healthy.

 

Trade relations are fair. Business is active. Payment terms are usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

We are living in a world where volatility and uncertainty have become the New Normal. We saw a change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once powerful countries in Europe are now fighting for bankruptcy. We have taken growth in the developing part of the world for granted but economic growth in China and India has begun to slow. Companies that were synonymous with their product categories just a few years ago are now no longer in existence. Kodak, the inventor of the digital camera had to wind up its operations, HMV, the British entertainment retailing company and Borders, once the second largest bookstore have shut down due to their inability to evolve their business models with the changing time. Readers’ Digest, Thomson Register are no more !

 

There is another megatrend happening. The World order is changing as economic power shifts from West to East. According to McKinsey study, it took Britain more than 100 years to double its economic output per person during its industrial revolution and the US later took more than 50 years to do the same. More than a century later, China and India have doubled their GDP per capital in 12 and 18 years respectively. By 2020, emerging Asia will become the world’s largest consuming block, overtaking North America.

 

The years after the outbreak of the global financial crisis, the world economy continues to remain fragile. The Indian economy demonstrated remarkable resilience in the initial years of the contagion but finally lost ground last year. GDP growth slowed down. Currency has been weakening. There is a marked deceleration in agriculture, industry and services. Dampening sentiment led to a cut-back in investment as well as private consumption expenditure.  Inflation remained at high levels fuelled by the pressure from the food and fuel sectors. The large fiscal and current account deficit s continued to cause grave concern. It is imperative that India regains its growth trajectory of 8-9 % sooner than later. This is crucially important given the need to create gainful livelihood opportunities for the millions living in poverty as also the large contingent of young people joining the job market every year.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (EMPLOYEE PROVIDENT FUND) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Jesal

Designation :

Accountant

Contact No.:

91-9909000366

Date :

16.10.2013

 

 

LOCATIONS

 

Registered Office :

12, Gunbow Street, Fort, Mumbai - 400001, Maharashtra, India

Tel. No.:

91-22-22611206

Fax No.:

91-22-22659376

E-Mail :

golden.cross@indiatimes.com

 

 

DIRECTORS

 

As on: 25.09.2012

 

Name :

Mr. Nitin Janardan Desai

Designation :

Director

Address :

204, Vasant Sagar Ganga, Thakur Village, Kandivali (East), Mumbai – 400101, Maharashtra, India

Date of Birth/Age :

20.09.1961

Date of Appointment :

25.09.2012

DIN No.:

00028060

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U73100MH1997PTC107712

ADVANCED REMEDIES PRIVATE LIMITED

Director

28/03/2002

28/03/2002

-

Active

NO

2

U24300MH2000PTC124843

INHALED TECHNOLOGIES PRIVATE LIMITED

Director

28/03/2002

28/03/2002

-

Active

NO

3

U73100MH2000PTC125679

ONCOCARE INDIA PRIVATE LIMITED

Director

28/03/2002

28/03/2002

-

Active

NO

4

U99999MH2000PTC126588

PHARMASOLVE SPECIALITIES INDIA PRIVATE LIMITED

Director

04/09/2002

04/09/2002

-

Active

NO

5

U24230MH2000PTC125757

ORION LIFE SCIENCES PRIVATE LIMITED

Director

18/09/2002

18/09/2002

02/05/2007

Converted to LLP and dissolved

NO

6

U28920MH2005PTC155573

G M PARTITIONS PRIVATE LIMITED

Director

01/12/2005

01/12/2005

-

Amalgamated

NO

7

U24230MH2000PTC126487

MEDICREAMS INDIA PRIVATE LIMITED

Director

01/03/2006

01/03/2006

02/05/2007

Converted to LLP and dissolved

NO

8

U51503MH2000PTC127277

MEDICON ENGINEERS (INDIA) PRIVATE LIMITED

Director

01/03/2006

01/03/2006

-

Active

NO

9

U23240MH1996PTC104442

MEDITAB SPECIALITIES PRIVATE LIMITED

Director

10/07/2006

10/07/2006

-

Active

NO

10

U24239MH2006PTC163872

MEDIMORE PHARMA PRIVATE LIMITED

Director

25/10/2007

08/09/2006

-

Strike off

NO

11

U24239MH2000PTC123766

GOLDENCROSS PHARMA PRIVATE LIMITED

Director

25/09/2012

04/11/2011

-

Active

NO

12

U51909WB2005PTC101975

COCETRA TRADE LINK PRIVATE LIMITED

Additional director

12/12/2012

12/12/2012

-

Active

NO

 

 

Name :

Mr. Rupesh Hemendra Shah

Designation :

Director

Address :

A-302, Sumadhuri II, Near Azad Society, Ambawadi, Ahmedabad – 380015, Gujarat, India

Date of Birth/Age :

03.07.1971

Date of Appointment :

20.09.2010

DIN No.:

00029134

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231GJ2001PTC039783

DHRUVI PHARMA PRIVATE LIMITED

Director

16/07/2001

16/07/2001

-

Active

NO

2

U51909GJ2003PTC042344

DHRUVI DISTRIBUTION SERVICES PRIVATE LIMITED

Director

06/05/2003

06/05/2003

-

Active

NO

3

U51109GJ2004PTC043792

YASHVI DISTRIBUTION SERVICES PRIVATE LIMITED

Director

16/03/2004

16/03/2004

-

Active

NO

4

U63063MH2004PTC146785

RR SHIPPING PRIVATE LIMITED

Director

07/06/2004

07/06/2004

-

Active

NO

5

U24230MH2000PTC126038

LANCET PHARMA PRIVATE LIMITED

Director

01/03/2006

01/03/2006

-

Active

NO

6

U74999MH2003PTC142312

GMP Technical Solutions Private Limited

Director

01/03/2006

01/03/2006

20/10/2010

Active

NO

7

U24239MH2006PTC162744

MEDWORLD PHARMACEUTICALS PRIVATE LIMITED

Director

25/10/2007

10/07/2006

20/04/2011

Active

NO

8

U24239MH2006PTC163872

MEDIMORE PHARMA PRIVATE LIMITED

Director

25/10/2007

08/09/2006

-

Strike off

NO

9

U24239MH2006PTC164764

GOLDEN TEMPLE PHARMA PRIVATE LIMITED

Additional director

01/11/2006

01/11/2006

02/05/2007

Converted to LLP and dissolved

NO

10

U24239MH2006PLC162743

GLOBUS HEALTHCARE LIMITED

Additional director

14/10/2009

14/10/2009

01/03/2010

Active

NO

11

U24230MH2005PTC156973

MEDIC REMEDIES PRIVATE LIMITED

Director

30/09/2010

14/10/2009

-

Active

NO

12

U24239MH2000PTC123766

GOLDENCROSS PHARMA PRIVATE LIMITED

Director

20/09/2010

13/04/2010

-

Active

NO

 

 

Name :

Mr. Davinder Singh Marwah

Designation :

Director

Address :

173/A, Kalpataru Residency, Sion East, Mumbai – 400022, Maharashtra, India

Date of Birth/Age :

18.05.1949

Date of Appointment :

20.09.2010

DIN No.:

01907935

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230MH1997PTC111089

BAKUL PHARMA PRIVATE LIMITED

Director

16/01/1998

16/01/1998

30/08/2007

Active

NO

2

U24239MH2000PTC123766

GOLDENCROSS PHARMA PRIVATE LIMITED

Director

20/09/2010

14/05/2010

-

Active

NO

3

U51900MH2008PTC186021

FOUR M PROPACK PRIVATE LIMITED

Director

21/09/2010

14/05/2010

-

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 25.09.2012

 

Names of Shareholders

 

No. of Shares

Cipla Limited, India

 

45960

Hamied K Mustafa Jointly with Cipla Limited, India

 

1

Hamied M Kamil Jointly with Cipla Limited, India

 

1

S Radhakrishnan Jointly with Cipla Limited, India

 

1

R Gopalkrishnan Jointly with Cipla Limited, India

 

1

Sanghvi A Mital Jointly with Cipla Limited, India

 

1

Athipotta Parameshwar Raman Jointly with Cipla Limited, India

 

1

Total

 

45966

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 25.09.2012

 

Category

Percentage

Bodies corporate

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

PRODUCTION STATUS AS ON 31.03.2011

(In Millions)

Particulars

Unit

Installed Capacity

Actual Production

Class of Goods

 

 

 

Tablets & Caps ules

Nos.

741.00

163.33

Dry Syrup

Nos.

21.00

17.35

Dry Powder Injections

Nos.

10.00

3.50

Shampoos

Nos.

6.50

1.39

Rediuse

Nos.

12.25

5.09

Oral Liq uids

Nos.

60.00

22.76

Creams/Gels

Nos.

9.00

3.58

Pet Bottles Aerosols

Nos.

135.00

61.96

 

Notes:

 

i. Actual production for all dosage forms includes production carried out by Golden Cross Pharma Private Limited at contract manufacturing sites.

 

ii. The installed capacity is as certified by the Management and not verified by the auditors, this being a technical matter.

 

 

GENERAL INFORMATION

 

No. of Employees :

Information declined by the management.

 

 

Bankers :

The Hongkong and Shanghai Banking Corporation Limited, 52/60 Mahatma Gandhi Road, Fort, Mumbai - 400001, Maharashtra, India

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2011

As on

31.03.2010

Rupee term loans banks

450.000

750.000

Total

450.000

750.000

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

V. Sankar Aiyar and Company

Chartered Accountants

Address :

2-C, Court Chambers, 35, New Marine Lines, Mumbai-400020, Maharashtra, India

PAN No.:

AAAFV0781D

 

 

Holding Company:

Cipla Limited

 

 

Subsidiary Company:

Four M Propack Private Limited

 

 

Fellow Subsidiaries:

·         Cipla FZE

·         Meditab Specialities Private Limited

·         Cipla (Mauritius) Limited

·         Medispray Laboratories Private Limited

·         Cipla (UK) Limited

·         Cipla -OZ Pty Limited

·         STD Chemicals Limited

·         Sitec Labs Private Limited

·         Meditab Holdings Limited

 

 

CAPITAL STRUCTURE

 

As on: 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100000

Equity Shares

Rs.10/- each

Rs.1.000 Million

390000

Preference Shares

Rs.100/- each

Rs.39.000 Millions

 

Total

 

Rs.40.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

45966

Equity Shares

Rs.10/- each

Rs.0.460 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.460

0.124

0.121

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

1825.009

473.935

442.599

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

1825.469

474.059

442.720

LOAN FUNDS

 

 

 

1] Secured Loans

450.000

750.000

900.000

2] Unsecured Loans

153.011

1168.957

897.600

TOTAL BORROWING

603.011

1918.957

1797.600

DEFERRED TAX LIABILITIES

1.529

2.708

1.819

 

 

 

 

TOTAL

2430.009

2395.724

2242.139

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

1546.130

1757.041

89.610

Capital work-in-progress

20.608

11.702

1947.755

 

 

 

 

INVESTMENT

143.051

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

200.268

172.811

0.000

 

Sundry Debtors

57.861

50.480

20.160

 

Cash & Bank Balances

21.184

30.446

48.044

 

Other Current Assets

0.000

0.000

26.490

 

Loans & Advances

616.408

590.667

169.450

Total Current Assets

895.721

844.404

264.144

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

136.292

117.780

150.140

 

Other Current Liabilities

37.109

98.279

97.278

 

Provisions

2.100

1.364

66.873

Total Current Liabilities

175.501

217.423

314.291

Net Current Assets

720.220

626.981

(50.147)

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

254.921

 

 

 

 

TOTAL

2430.009

2395.724

2242.139


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

1542.415

1381.869

120.170

 

 

Other Income

 

 

 

 

 

TOTAL                                    

1542.415

1381.869

120.170

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

1370.799

1109.650

87.142

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

1370.799

1109.650

87.142

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION                                      

171.616

272.219

33.028

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

217.432

243.655

7.076

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX                          

(45.816)

28.564

25.952

 

 

 

 

 

Less

TAX                                                                 

(1.179)

6.278

6.033

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX                           

(44.637)

22.286

19.919

 

 

 

 

 

 

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

420.501

398.215

378.296

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

375.864

420.501

398.215

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

(971.09)

484.84

433.34

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

(2.89)

1.61

16.58

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(1.88)

1.10

7.34

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.02)

0.06

0.06

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.33

4.05

4.06

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

5.10

3.88

0.84

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOAN

(Rs. In Millions)

Particulars

As on

31.03.2011

As on

31.03.2010

Rupee term loans others

150.000

745.500

Other debt

0.000

345.000

Interest accrued due other

3.011

78.457

Total

153.011

1168.957

 

 

OPERATIONS:

 

The Gross Income from Operations for the year under review was Rs. 1542.415 Millions, resulting in a net loss after Tax Rs 45.816 Millions.

 

 

INDEX OF CHARGES

 

S. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

90237480

18/03/2002

7,500,000.00

CREDIT LYONNIAS

APEEJAY HOUSE; 3 3 DINSHAV VACHHA ROAD, MUMBAI, Maharashtra - 400020, INDIA

-

2

90237477

08/03/2002

7,500,000.00

CREDIT LYONNIAS

APEEJAY HOUSE; 3 3 DINSHAV VACHHA ROAD, MUMBAI, Maharashtra - 400020, INDIA

-

 

* Date of charge modification

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant machinery

·         Office equipments

·         Furniture fixtures

·         Vehicles

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.58

UK Pound

1

Rs.98.51

Euro

1

Rs.83.49

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Report Prepared by :

RAJ

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

42

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.